- Projects & figures
- News & Events
- Managing your project
- About ERC
Quantum computers are the Holy Grail of information theorists. For years, scientists have been trying to crack their mysteries, to harvest their interesting applications. They are predicted to have tremendous computational power, exponentially larger than the computers available today. However, so far, they have been difficult to actually build. Prof. Ashley Montanaro will investigate the path from the theoretical foundations of quantum computing their applications to real-life problems.
ELECTION SERIES #3
The traditional pencil-and-paper method to mark your vote in the polling booth has been gradually replaced by electronic voting machines in many countries, in Europe and beyond. Ensuring the security of electronic voting machines and quelling fears of vote-rigging have become ever more important. One ERC-funded researcher has been working tirelessly to develop such an e-voting system through two projects, SEEVS and its follow-up SEEVCA.
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancer
Pancreatic cancer is the 4th leading cause of death by cancer in Europe. It has a very low survival rate with less than 1 per cent of sufferers surviving for 10 or more years. Over the last 40 years the survival rate has not significantly changed and finding an effective therapy has become a pressing challenge in cancer research. A team based at Imperial College London led by Armando Del Río Hernández, has now demonstrated that a well-known drug could be effective to fight this deadly and other forms of cancer, such as liver cancer.
The increasing development of wearable technology sparks the need for new, innovative ways to interact with our shiny gadgets. Deviating from the conventional approach based on touch-sensitive devices, Prof. Jürgen Steimle aims at producing body-worn user interfaces that can be applied directly on the skin. Highly personalised, biocompatible and ultrathin, these devices will seamlessly blend with the human skin to create a technological extension of our body.
The amount of currently available biomedical data is overwhelming. Large databases exist at different scales, from genes, to proteins, to patients' histories. But what do scientists do with all this information? Serbian-born Professor Nataša Pržulj, from University College London, works with Big Data to establish patterns and gain knowledge that could revolutionise how we treat diseases.
CRISPR is a widely used molecular biology tool exploiting an immune process discovered in bacteria. Dr David Bikard studies CRISPR in bacterial cells, in conjunction with different DNA repair systems, to create even newer tools. He hopes to gain insight into bacterial genetics, and develop increasingly effective medical treatments.
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional organoid cultures that replicate genetic events in CRC, as tools to test novel therapeutics.
Travellers already benefit from applications harnessing data from sensor networks and smartphone users. They calculate alternative routes, help plan carpooling routes, or support the optimisation of public transport. With her ERC grant, Prof. Vana Kalogeraki works on a comprehensive software framework that will simplify the development of such mobile human-centred systems and make them more predictable and reliable.
Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up, specialised in cell based therapies, including novel solutions to multiply the scarcely available blood stem cells, addressing an enormous demand for research and cancer treatment. StemCell2MAX technology is based on Prof. Veiga-Fernandes's ground-breaking discoveries in hematopoietic stem cell biology.
Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."
An ERC-funded project has significantly increased understanding of the crucial role that microorganisms in the gut play in maintaining health. The findings have since led to a patent, as well as a follow-on project that could one day steer the way to new targeted treatments for diseases, including cancer.